Cannabis compounds may have effect on agitation in dementia

Certain compounds from cannabis could, according to a publication by EOS Science, play a role in reducing agitation in people with dementia. The source emphasizes that these are preliminary findings, without hard conclusions about effectiveness or safety.

The substances in question are known as cannabinoids. According to the researchers, these could influence behavioral symptoms that often occur in dementia, such as agitation and anxiety. This is an exploratory study, in which no concrete treatment methods have been proposed.

Whether and how these substances could be used in practice remains a subject of further research. EOS Science points out that there is still much uncertainty about dosage, side effects, and long-term effects in this vulnerable group.

This report is a summary based on the mentioned source and is not medical advice. Consult a doctor or pharmacist in case of complaints.